Latest releases

04.09.2020

GR, PR

Herantis Pharma Plc Announces Appointment of Investor Relations Team
27.08.2020

CR, PR

Herantis Pharma Plc Announces CDNF Phase I-II Study Met Primary Endpoints of Safety and Tolerability at 12 months
25.08.2020

ER, GR

Herantis Pharma Plc announces half year financial report January 1 – June 30, 2020 (unaudited)
06.07.2020

N, PR

Herantis Pharma publishes newsletter for May-June
18.06.2020

GR, IT

Herantis Pharma Oyj: Manager’s Transactions – Henri Huttunen
18.06.2020

GR, IT

Herantis Pharma Oyj: Manager’s Transactions – Pekka Simula
18.06.2020

FN, GR

Herantis Pharma Plc’s shares subscribed with option rights
27.05.2020

FN, GR

New shares in Herantis Pharma Plc registered with the trade register
27.05.2020

FN, GR

Herantis Pharma Plc to raise EUR 6.8 million as a result of the directed offering
26.05.2020

FN, GR

Herantis Pharma Plc launches a directed offering of new shares to raise a minimum of EUR 5 million

Quick links

Herantis in the News »

Public materials »

Video Presentations »